PA DOH Patient Advocacy Program Alert: DEA License Suspensions

PAMED has been informed by the Pennsylvania Department of Health (DOH) that several providers have had their DEA licenses revoked, which means the providers are currently unable to prescribe controlled substances. 

Most patients impacted by this event were receiving opioids and/or buprenorphine and will likely come from Philadelphia, Bucks, Delaware, and Montgomery counties. Patients impacted by this event may be seeking resources to re-establish care, specifically for the treatment of pain and/or substance use disorder. 

Patients treated long-term with opioids may be physically dependent on their medicine which means they are at risk of severe medication withdrawal, including pain and psychological distress, if care is not quickly re-established. Patients who are prescribed buprenorphine for opioid use disorder may need to re-establish care with a new treatment provider as soon as possible.

If you have practice in the above counties, you may receive an increase in calls or visits from patients because of this incident.

Please find more information and resources here.